Citation Impact
Citing Papers
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
2009 Standout
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
2016
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
2009
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Biologic markers determine both the risk and the timing of recurrence in breast cancer
2011
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
2011 Standout
Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules
2010
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer
2012
Independent and functional validation of a multi-tumour-type proliferation signature
2012
Is gene array testing to be considered routine now?
2011
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
2011 Standout
Triple-Negative Breast Cancer
2010 Standout
Adjuvant Therapy in Stage I Carcinoma of the Breast: The Influence of Multigene Analyses and Molecular Phenotyping
2012
The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade
2009
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX
2011
A view on drug resistance in cancer
2019 StandoutNature
Personalized treatment of early-stage breast cancer: Present concepts and future directions
2010
Breast cancer
2016 Standout
Gene Expression-Based Prognostic Signatures in Lung Cancer: Ready for Clinical Use?
2010
Molecular and protein markers for clinical decision making in breast cancer: Today and tomorrow
2013
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
GeneSigDB—a curated database of gene expression signatures
2009
Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
2009
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
2011 Standout
The multilayered complexity of ceRNA crosstalk and competition
2014 StandoutNature
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
2008
Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement
2013
The landscape of long noncoding RNAs in the human transcriptome
2015 Standout
TLR4 links innate immunity and fatty acid–induced insulin resistance
2006 Standout
Breast Cancer Metastasis
2013
Population-based screening for cancer: hope and hype
2016
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
High-performance medicine: the convergence of human and artificial intelligence
2018 Standout
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
2001 Standout
Immune parameters affecting the efficacy of chemotherapeutic regimens
2011
Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery
2007
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Gene expression predictors in breast cancer: Current status, limitations and perspectives
2008
Palmitate Activates the NF-κB Transcription Factor and Induces IL-6 and TNFα Expression in 3T3-L1 Adipocytes
2005
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer
2008
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Gene-Expression Signatures in Breast Cancer
2009
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis
2011 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
GOBO: Gene Expression-Based Outcome for Breast Cancer Online
2011
Late Recurrences in Early Breast Cancer: For Whom and How Long Is Endocrine Therapy Beneficial?
2014
Adjuvant therapy in stage I carcinoma of the breast
2012
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
2017
Emerging gene-based prognostic tools in early breast cancer: First steps to personalised medicine
2014
Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients
2013
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
2014 Standout
Artificial intelligence in healthcare
2018 Standout
The prognostic landscape of genes and infiltrating immune cells across human cancers
2015 Standout
A Hepatocellular Carcinoma 5-Gene Score Associated With Survival of Patients After Liver Resection
2013
Artificial Intelligence and Machine Learning in Clinical Medicine, 2023
2023 Standout
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
2015 Standout
Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction
2006 Standout
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
2003 Standout
NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology
2011
Cancer-associated regulation of alternative splicing
2009
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
Why Most Gene Expression Signatures of Tumors Have Not Been Useful in the Clinic
2010
Breast Cancer Treatment
2019 Standout
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
2001 Standout
Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial
2009
A Combined Shotgun and Targeted Mass Spectrometry Strategy for Breast Cancer Biomarker Discovery
2015
Metabolic reprogramming and cancer progression
2020 StandoutScience
Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades
2017
Molecular signatures database (MSigDB) 3.0
2011 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
2014 Standout
Reshaping de Novo Protein Switches into Bioresponsive Materials for Biomarker, Toxin, and Viral Detection
2022 StandoutNobel
Improving Validation Practices in “Omics” Research
2011 Science
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Shining Light into Black Boxes
2012 StandoutScienceNobel
Immune Checkpoint Blockade in Cancer Therapy
2015 Standout
A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study
2013
Chemical Glycoproteomics
2016 StandoutNobel
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
2017
Works of Stella Mook being referenced
Additional prognostic value of the 70-gene signature (MammaPrint®) among breast cancer patients with 4–9 positive lymph nodes
2013
Metastatic Potential of T1 Breast Cancer can be Predicted by the 70-gene MammaPrint Signature
2010
The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study
2008
Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study
2009
A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the Proliferation, Immune response and RNA splicing modules in breast cancer
2008
Impact of mammographic screening on the detection of good and poor prognosis breast cancers
2011
The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer
2010
Daily clinical practice of fresh tumour tissue freezing and gene expression profiling; logistics pilot study preceding the MINDACT trial
2009
The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age
2009
Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial
2006
In vivo regulation of plasma free fatty acids in insulin resistance
2004
Clinical Application of the 70-Gene Profile: The MINDACT Trial
2008